Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Mofid Pharmaceutical is a prominent Iranian pharmaceutical company specializing in the development and manufacturing of generic medicinal products. Headquartered in Tehran, the company operates as a key subsidiary of the Barkat Pharmaceutical Group, contributing significantly to the national healthcare infrastructure. Mofid's extensive portfolio covers diverse therapeutic categories, including cardiovascular, central nervous system, gastrointestinal, and anti-infective agents. The company maintains advanced manufacturing facilities that adhere to Good Manufacturing Practice (GMP) standards to ensure high-quality production of tablets, capsules, and syrups. Through its commitment to affordability and quality, Mofid Pharmaceutical plays a vital role in meeting the domestic demand for essential medicines in Iran and the surrounding region. The company also explores export opportunities to neighboring markets in Central Asia and the Middle East. Its strategic alignment with the Barkat Group allows it to leverage extensive research and distribution networks across the country.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Mofid Pharmaceutical.